interleukin-11 inhibitors (CSL)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameinterleukin-11 inhibitors (CSL)
Drug Alias NameIL-11 inhibitors (CSL)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-11 receptors antagonists
TargetsInterleukin-11 receptors
Therapy Area/IndicationsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCsl Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCsl Ltd
Active IndicationsN/A
Inactive IndicationsGastrointestinal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A